Related Experiment Video
Updated: May 16, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
A tiered-layered-staged model for informed consent in personal genome testing
Eline M Bunnik1, A Cecile J W Janssens, Maartje H N Schermer
1Department of Medical Ethics and Philosophy of Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. e.bunnik@erasmusmc.nl
European Journal of Human Genetics : EJHG
|November 22, 2012
Summary
Commercial personal genome testing (PGT) presents challenges for informed consent. This paper proposes a tiered-layered-staged model to improve information provision and ethical considerations for consumers undergoing PGT.
Area of Science:
- Genomics and Personalized Medicine
- Bioethics
- Consumer Health Information
Background:
- Commercial personal genome testing (PGT) offers broad, simultaneous disease risk assessment directly to consumers.
- The volume and complexity of PGT information challenge traditional informed consent processes.
- Current guidelines for informed consent in PGT are lacking.
Purpose of the Study:
- To address the ethical challenges in informed consent for direct-to-consumer PGT.
- To propose a novel model for informed consent in the context of PGT.
- To enhance consumer understanding and autonomy in PGT.
Main Methods:
- Development of a tiered-layered-staged informed consent model.
- Categorization of diseases based on ethical, personal, or societal implications (tiered).
- Progressive information delivery through layers and stages, including updates.
Main Results:
- The proposed model offers consumer choice through disease categories.
- Information is presented in layers, starting with essential details and offering more upon request.
- Consent is a process, accommodating ongoing scientific advancements and result updates.
Conclusions:
- A tiered-layered-staged model can improve informed consent for PGT consumers.
- This approach addresses ethical issues related to information provision in direct-to-consumer genetic testing.
- Focusing on the consumer perspective is key to successful PGT informed consent.

